Jazz Pharmaceuticals plc — Director's Dealing 2011

Feb 16, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-02-08

Reporting Person: Eller Mark G. (SVP, Research & Clinical Dev.)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$15.09	2015-06-14	Common Stock (14457)		Direct
Option (right to buy)	$13.25	2017-08-12	Common Stock (4659)		Direct
Option (right to buy)	$7.96	2018-05-15	Common Stock (9377)		Direct
Option (right to buy)	$1.25	2019-01-20	Common Stock (27223)		Direct
Option (right to buy)	$11.48	2020-03-07	Common Stock (35000)		Direct
Restricted Stock Units	$	2011-08-13	Common Stock (690)		Direct

Footnotes

F1: This option vested over four years measured from the vesting commencement date, May 9, 2005, with 1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter.

F2: This option, originally covering 19,615 shares, vests over four years measured from the vesting commencement date, August 13, 2007, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter, and was exercised in part prior to the date hereof.

F3: This option, originally covering 25,000 shares, vests over four years measured from the vesting commencement date, May 7, 2008, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter, and was exercised in part prior to the date hereof.

F4: This option, originally covering 70,000 shares, vests over three years measured from the vesting commencement date, January 21, 2009, with 1/3rd vesting on the first anniversary of the vesting commencement date and the remainder vesting in 24 equal monthly installments thereafter, and was exercised in part prior to the date hereof.

F5: This option vests over four years measured from the vesting commencement date, March 8, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.

F6: 100% of the restricted stock units are scheduled to vest on August 13, 2011, assuming continued employment through the vesting date.

F7: Each restricted stock unit represents a contingent right to receive one share of common stock upon the vesting of the unit.